Cargando…

Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome

The mechanisms by which glucocorticoids regulate food intake and resulting body mass in humans are not well-understood. One potential mechanism could involve modulation of reward processing, but human stress models examining effects of glucocorticoids on behavior contain important confounds. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moeller, Scott J., Couto, Lizette, Cohen, Vanessa, Lalazar, Yelena, Makotkine, Iouri, Williams, Nia, Yehuda, Rachel, Goldstein, Rita Z., Geer, Eliza B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742561/ https://www.ncbi.nlm.nih.gov/pubmed/26903790 http://dx.doi.org/10.3389/fnins.2016.00021

Ejemplares similares

Maternal Age at Holocaust Exposure and Maternal PTSD Independently Influence Urinary Cortisol Levels in Adult Offspring
por: Bader, Heather N., et al.
Publicado: (2014)

Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study
por: Pivonello, Rosario, et al.
Publicado: (2021)

Disturbed bone marrow adiposity in patients with Cushing’s syndrome and glucocorticoid- and postmenopausal- induced osteoporosis
por: Sørensen, Nina N., et al.
Publicado: (2023)

MON-321 AgRP and Food Cravings Decrease with Treatment of Cushing’s Disease
por: Haseltine, Katherine N, et al.
Publicado: (2020)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
por: Gao, Chang, et al.
Publicado: (2023)

Iatrogenic Cushing’s Syndrome: The Result of Cobicistat and Glucocorticoid Interaction in an HIV Patient After Bariatric Surgery
por: Benido Silva, Vânia, et al.
Publicado: (2023)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome
por: Di Vincenzo, Mariangela, et al.
Publicado: (2022)

Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations
por: Detomas, Mario, et al.
Publicado: (2021)

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
por: Pivonello, Rosario, et al.
Publicado: (2021)

Factitious Cushing's Syndrome: A Diagnosis to Consider When Evaluating Hypercortisolism
por: Pineyro, Maria M., et al.
Publicado: (2019)

Diabetes Mellitus Secondary to Cushing’s Disease
por: Barbot, Mattia, et al.
Publicado: (2018)

Pituitary-Directed Therapies for Cushing’s Disease
por: Langlois, Fabienne, et al.
Publicado: (2018)

Quality of Life in Patients With Cushing's Disease
por: Santos, Alicia, et al.
Publicado: (2019)

Cushing’s Disease Management: Glimpse Into 2051
por: Dalan, Rinkoo, et al.
Publicado: (2022)

Functional brain alterations in Cushing’s syndrome
por: Papakokkinou, Eleni, et al.
Publicado: (2023)

Site-specific methylation changes in the glucocorticoid receptor exon 1F promoter in relation to life adversity: systematic review of contributing factors
por: Daskalakis, Nikolaos P., et al.
Publicado: (2014)

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
por: Pivonello, Rosario, et al.
Publicado: (2022)

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
por: Barbot, Mattia, et al.
Publicado: (2019)

Toward a Diagnostic Score in Cushing's Syndrome
por: Braun, Leah T., et al.
Publicado: (2019)

Circulating microRNA Expression in Cushing’s Syndrome
por: Vetrivel, Sharmilee, et al.
Publicado: (2021)

Cyclic Cushing’s Syndrome – A Diagnostic Challenge
por: Świątkowska-Stodulska, Renata, et al.
Publicado: (2021)

Individualized medical treatment options in Cushing disease
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2022)

Cushing’s syndrome is associated with altered adipokine profile
por: Dadej, Daniela, et al.
Publicado: (2022)

Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2019)

Medical treatment of Cushing’s disease with concurrent diabetes mellitus
por: Mehlich, Anna, et al.
Publicado: (2023)

Emerging diagnostic methods and imaging modalities in cushing’s syndrome
por: Wright, Kyla, et al.
Publicado: (2023)

THU040 Different Patient Versus Provider Perspectives On Living With Cushing’s Disease
por: Halstrom, Amanda, et al.
Publicado: (2023)

Sex Differences in Presentation but Not in Outcome for ACTH-Dependent Cushing's Syndrome
por: Broersen, Leonie H. A., et al.
Publicado: (2019)

Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism
por: Kamilaris, Crystal D. C., et al.
Publicado: (2021)

Cortisol and Phosphate Homeostasis: Cushing’s Syndrome Is Associated With Reversible Hypophosphatemia
por: Bosman, Ariadne, et al.
Publicado: (2021)

Aggressive Cushing’s Disease: Molecular Pathology and Its Therapeutic Approach
por: Yamamoto, Masaaki, et al.
Publicado: (2021)

Editorial: Current Clinical and Pre-Clinical Progress in Cushing’s Disease
por: Stalla, Günter Karl, et al.
Publicado: (2020)

Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1
por: Simonds, William F.
Publicado: (2023)

The patient’s sex determines the hemodynamic profile in patients with Cushing disease
por: Jurek, Agnieszka, et al.
Publicado: (2023)

Choroidal and Retinal Abnormalities by Optical Coherence Tomography in Endogenous Cushing’s Syndrome
por: Abalem, Maria Fernanda, et al.
Publicado: (2016)

Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
por: Araki, Takako, et al.
Publicado: (2018)

Regulation of the EGFR Pathway by HSP90 Is Involved in the Pathogenesis of Cushing’s Disease
por: Shen, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3j86idgmn68ng6c3f0j37uad25